id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0372-0002,FDA,FDA-2004-D-0372,Guideline,Supporting & Related Material,GDL-Guidance,2004-11-10T05:00:00Z,2004,11,,,2008-04-12T00:35:59Z,,0,0,0900006480473709
FDA-2004-D-0372-0001,FDA,FDA-2004-D-0372,FDA,Notice,NAD-Notice of Availability of Data,2004-11-10T05:00:00Z,2004,11,2004-11-09T05:00:00Z,2005-01-30T04:59:59Z,2015-09-11T01:30:42Z,,0,0,0900006480473706
FDA-2004-D-0372-0003,FDA,FDA-2004-D-0372,Guideline,Supporting & Related Material,GDL-Guidance,2004-11-10T05:00:00Z,2004,11,,,2008-04-12T00:35:59Z,,0,0,090000648047370a